Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernst R Dow

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Bio Systems|June 9, 2005
A statistical analysis of the TRANSFAC databaseGary B Fogel, Dana G Weekes, Gabor Varga, et al.
Annals of the Rheumatic Diseases|May 24, 2022
Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosusThomas Dörner, Yoshiya Tanaka, Ernst R Dow, et al.
Obesity (Silver Spring, Md.)|February 2, 2008
Assessment of diet-induced obese rats as an obesity model by comparative functional genomicsShuyu Li, Hong-Yan Zhang, Charlie C Hu, et al.
Plos One|December 3, 2019
A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosusYupeng Li, Richard E Higgs, Robert W Hoffman, et al.
Nucleic Acids Research|October 18, 2008
Evolutionary computation for discovery of composite transcription factor binding sitesGary B Fogel, V William Porto, Gabor Varga, et al.
Frontiers in Immunology|April 27, 2026
XIST expression and hypermethylation of the X chromosome in males with systemic lupus erythematosusHelen O Masson, Jonathan D Crawford, David C Gemperline, et al.
The Journal of Investigative Dermatology|August 16, 2025
Comparative molecular analysis of IL-17A and IL-23 pathway inhibition in moderate-to-severe psoriasis: 4-week results from IXORA-RSandra Garcet, Lam C Tsoi, Hong Hur, et al.
Lupus Science & Medicine|October 10, 2020
Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathwaysThomas Dörner, Yoshiya Tanaka, Michelle A Petri, et al.
Molecular Pharmacology|August 5, 2005
Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifeneLeah M Helvering, Riting Liu, Nalini H Kulkarni, et al.
Journal of Cellular Biochemistry|May 24, 2007
Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitorNalini H Kulkarni, Tao Wei, Amar Kumar, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Bio Systems|June 9, 2005
A statistical analysis of the TRANSFAC databaseGary B Fogel, Dana G Weekes, Gabor Varga, et al.
Annals of the Rheumatic Diseases|May 24, 2022
Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosusThomas Dörner, Yoshiya Tanaka, Ernst R Dow, et al.
Obesity (Silver Spring, Md.)|February 2, 2008
Assessment of diet-induced obese rats as an obesity model by comparative functional genomicsShuyu Li, Hong-Yan Zhang, Charlie C Hu, et al.
Plos One|December 3, 2019
A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosusYupeng Li, Richard E Higgs, Robert W Hoffman, et al.
Nucleic Acids Research|October 18, 2008
Evolutionary computation for discovery of composite transcription factor binding sitesGary B Fogel, V William Porto, Gabor Varga, et al.
Frontiers in Immunology|April 27, 2026
XIST expression and hypermethylation of the X chromosome in males with systemic lupus erythematosusHelen O Masson, Jonathan D Crawford, David C Gemperline, et al.
The Journal of Investigative Dermatology|August 16, 2025
Comparative molecular analysis of IL-17A and IL-23 pathway inhibition in moderate-to-severe psoriasis: 4-week results from IXORA-RSandra Garcet, Lam C Tsoi, Hong Hur, et al.
Lupus Science & Medicine|October 10, 2020
Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathwaysThomas Dörner, Yoshiya Tanaka, Michelle A Petri, et al.
Molecular Pharmacology|August 5, 2005
Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifeneLeah M Helvering, Riting Liu, Nalini H Kulkarni, et al.
Journal of Cellular Biochemistry|May 24, 2007
Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitorNalini H Kulkarni, Tao Wei, Amar Kumar, et al.
Pageof 3